{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:00:56Z","timestamp":1784880056731,"version":"3.55.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","award":["RC-2025-2795998"],"award-info":[{"award-number":["RC-2025-2795998"]}],"id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bile salt export pump (BSEP) deficiency, also termed progressive familial intrahepatic cholestasis type 2 (PFIC2), is a rare genetic disorder caused by mutations in the ATP-binding cassette, sub-family B member 11 (ABCB11) gene, predisposing to cholestasis and progressive liver damage. Although parvovirus B19 is a recognized but rare cause of acute hepatitis in children, its role in adult liver disease remains uncertain. To expand the knowledge on this topic, we performed a narrative review of published adult cases of B19-associated hepatitis and report the case of a 46-year-old immunocompetent man who developed acute cholestatic hepatitis during B19 infection. The clinical course was not fully attributable to the viral insult alone, prompting further evaluation. Liver histology demonstrated marked loss of BSEP immunoreactivity, and genetic testing identified a heterozygous ABCB11 variant. Despite treatment with ursodeoxycholic acid and cholestyramine, the symptoms persisted, leading to the introduction of the ileal bile acid transporter (IBAT) inhibitor, odevixibat, which resulted in rapid relief of pruritus and near-complete biochemical normalization within 2\u00a0months. Our review identified 32 published adult cases of B19-associated hepatitis. Most patients were immunocompetent, with presentations ranging from mild hepatic dysfunction to fulminant liver failure requiring transplantation. In more than half of the patients, predisposing factors such as hematologic disorders or viral co-infections were identified. This review highlights the importance of considering parvovirus B19 infection in the differential diagnosis of acute hepatitis in adults and of investigating potential underlying predisposing factors when the clinical course cannot be fully explained by the viral infection alone.<\/jats:p>","DOI":"10.1007\/s11739-026-04464-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:51:42Z","timestamp":1784872302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Parvovirus B19 infection as a trigger of acute cholestasis in heterozygous genetic BSEP deficiency: a case report and review of the literature of acute parvovirus B19-related hepatitis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1457-0076","authenticated-orcid":false,"given":"Madalina-Gabriela","family":"Indre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Boe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Malvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Marseglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Lazzarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Piscaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"6","key":"4464_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMra030840","volume":"350","author":"NS Young","year":"2004","unstructured":"Young NS, Brown KE (2004) Parvovirus B19. N Engl J Med 350(6):586\u2013597","journal-title":"N Engl J Med"},{"issue":"9142","key":"4464_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(98)06165-0","volume":"352","author":"EM Sokal","year":"1998","unstructured":"Sokal EM, Melchior M, Cornu C, Vandenbroucke AT, Buts JP, Cohen BJ et al (1998) Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 352(9142):1739\u20131741","journal-title":"Lancet"},{"issue":"8922","key":"4464_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0140-6736(94)92014-1","volume":"344","author":"Y Yoto","year":"1994","unstructured":"Yoto Y, Kudoh T, Asanuma H, Numazaki K, Tsutsumi Y, Nakata S et al (1994) Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet 344(8922):624\u2013625","journal-title":"Lancet"},{"issue":"4","key":"4464_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jmii.2019.05.009","volume":"52","author":"JY Sim","year":"2019","unstructured":"Sim JY, Chang LY, Chen JM, Lee PI, Huang LM, Lu CY (2019) Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect 52(4):534\u2013541","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"4464_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.4306\/pi.2016.13.5.580","volume":"13","author":"G Vitale","year":"2016","unstructured":"Vitale G, Simonetti G, Pirillo M, Taruschio G, Andreone P (2016) Bipolar and related disorders induced by sodium 4-phenylbutyrate in a male adolescent with bile salt export pump deficiency disease. Psychiatry Investig 13(5):580\u2013582","journal-title":"Psychiatry Investig"},{"issue":"3","key":"4464_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/MPG.0000000000001203","volume":"63","author":"N Had\u017ei\u0107","year":"2016","unstructured":"Had\u017ei\u0107 N, Verkade HJ (2016) The changing spectrum of neonatal hepatitis. J Pediatr Gastroenterol Nutr 63(3):316\u2013319","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4464_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.06.027","author":"G Vitale","year":"2025","unstructured":"Vitale G, Turco L, Azzaroli F, Piscaglia F (2025) The \u201cABC\u201d of genetics in cholestatic liver diseases. Dig Liver Dis. https:\/\/doi.org\/10.1016\/j.dld.2025.06.027","journal-title":"Dig Liver Dis"},{"issue":"4","key":"4464_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.siny.2009.01.007","volume":"14","author":"T Tolfvenstam","year":"2009","unstructured":"Tolfvenstam T, Broliden K (2009) Parvovirus B19 infection. Semin Fetal Neonatal Med 14(4):218\u2013221","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"4464_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","volume":"152","author":"MJ Anderson","year":"1985","unstructured":"Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM et al (1985) Experimental parvoviral infection in humans. J Infect Dis 152(2):257\u2013265","journal-title":"J Infect Dis"},{"issue":"6","key":"4464_CR10","first-page":"1661","volume":"22","author":"AN Langnas","year":"1995","unstructured":"Langnas AN, Markin RS, Cattral MS, Naides SJ (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22(6):1661\u20131665","journal-title":"Hepatology"},{"issue":"5","key":"4464_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1056\/NEJM198707303170506","volume":"317","author":"GJ Kurtzman","year":"1987","unstructured":"Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS (1987) Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 317(5):287\u2013294","journal-title":"N Engl J Med"},{"issue":"11","key":"4464_CR12","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/S0950268807009958","volume":"136","author":"C R\u00f6hrer","year":"2008","unstructured":"R\u00f6hrer C, G\u00e4rtner B, Sauerbrei A, B\u00f6hm S, Hottentr\u00e4ger B, Raab U et al (2008) Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 136(11):1564\u20131575","journal-title":"Epidemiol Infect"},{"issue":"2","key":"4464_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"BJ Cohen","year":"1988","unstructured":"Cohen BJ, Buckley MM (1988) The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25(2):151\u2013153","journal-title":"J Med Microbiol"},{"issue":"1","key":"4464_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/fmb-2020-0123","volume":"16","author":"R Cnc Garcia","year":"2021","unstructured":"Cnc Garcia R, Leon LAA (2021) Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil. Future Microbiol 16(1):37\u201350","journal-title":"Future Microbiol"},{"issue":"4","key":"4464_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009434","volume":"17","author":"J Bieri","year":"2021","unstructured":"Bieri J, Leisi R, Bircher C, Ros C (2021) Human parvovirus B19 interacts with globoside under acidic conditions as an essential step in endocytic trafficking. PLoS Pathog 17(4):e1009434","journal-title":"PLoS Pathog"},{"issue":"1","key":"4464_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/CMR.00040-16","volume":"30","author":"J Qiu","year":"2017","unstructured":"Qiu J, S\u00f6derlund-Venermo M, Young NS (2017) Human parvoviruses. Clin Microbiol Rev 30(1):43\u2013113","journal-title":"Clin Microbiol Rev"},{"key":"4464_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/v12121463","author":"C Ros","year":"2020","unstructured":"Ros C, Bieri J, Leisi R (2020) The VP1u of human parvovirus B19: a multifunctional capsid protein with biotechnological applications. Viruses. https:\/\/doi.org\/10.3390\/v12121463","journal-title":"Viruses"},{"issue":"3","key":"4464_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1155\/2005\/853947","volume":"19","author":"JK Ho","year":"2005","unstructured":"Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM et al (2005) Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol 19(3):161\u2013162","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"4464_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1423-0410.1997.00001.x","volume":"72","author":"C Prowse","year":"1997","unstructured":"Prowse C, Ludlam C, Yap P (1997) Human parvovirus B19 and blood products. Vox Sang 72(1):1\u201310","journal-title":"Vox Sang"},{"issue":"5907","key":"4464_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/302426a0","volume":"302","author":"PP Mortimer","year":"1983","unstructured":"Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS (1983) A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302(5907):426\u2013429","journal-title":"Nature"},{"issue":"1","key":"4464_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1046\/j.1365-2141.2000.01818.x","volume":"108","author":"M Hino","year":"2000","unstructured":"Hino M, Ishiko O, Honda KI, Yamane T, Ohta K, Takubo T et al (2000) Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 108(1):194\u2013195","journal-title":"Br J Haematol"},{"issue":"2","key":"4464_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/jmv.1890350207","volume":"35","author":"DD Erdman","year":"1991","unstructured":"Erdman DD, Usher MJ, Tsou C, Caul EO, Gary GW, Kajigaya S et al (1991) Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 35(2):110\u2013115","journal-title":"J Med Virol"},{"issue":"12","key":"4464_CR23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S1701-2163(15)30390-X","volume":"36","author":"J Crane","year":"2014","unstructured":"Crane J, Mundle W, Boucoiran I (2014) Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can 36(12):1107\u20131116","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"4464_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0268-960X(95)90023-3","volume":"9","author":"KE Brown","year":"1995","unstructured":"Brown KE, Young NS (1995) Parvovirus B19 infection and hematopoiesis. Blood Rev 9(3):176\u2013182","journal-title":"Blood Rev"},{"issue":"9005","key":"4464_CR25","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0140-6736(96)91348-3","volume":"347","author":"Y Yoto","year":"1996","unstructured":"Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S (1996) Human parvovirus B19 infection associated with acute hepatitis. Lancet 347(9005):868\u2013869","journal-title":"Lancet"},{"issue":"8462","key":"4464_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(85)90558-6","volume":"2","author":"PP Mortimer","year":"1985","unstructured":"Mortimer PP, Cohen BJ, Buckley MM, Cradock-Watson JE, Ridehalgh MK, Burkhardt F et al (1985) Human parvovirus and the fetus. Lancet 2(8462):1012","journal-title":"Lancet"},{"issue":"1","key":"4464_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0950-3536(89)80007-1","volume":"2","author":"G Kurtzman","year":"1989","unstructured":"Kurtzman G, Young N (1989) Viruses and bone marrow failure. Baillieres Clin Haematol 2(1):51\u201367","journal-title":"Baillieres Clin Haematol"},{"issue":"12","key":"4464_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020343","volume":"2","author":"A Isa","year":"2005","unstructured":"Isa A, Kasprowicz V, Norbeck O, Loughry A, Jeffery K, Broliden K et al (2005) Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med 2(12):e343","journal-title":"PLoS Med"},{"issue":"4","key":"4464_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/ijmr.IJMR_533_18","volume":"148","author":"J Kishore","year":"2018","unstructured":"Kishore J, Kishore D (2018) Clinical impact & pathogenic mechanisms of human parvovirus B19: a multiorgan disease inflictor incognito. Indian J Med Res 148(4):373\u2013384","journal-title":"Indian J Med Res"},{"issue":"22","key":"4464_CR30","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.1128\/JVI.01143-10","volume":"84","author":"C B\u00f6nsch","year":"2010","unstructured":"B\u00f6nsch C, Zuercher C, Lieby P, Kempf C, Ros C (2010) The globoside receptor triggers structural changes in the B19 virus capsid that facilitate virus internalization. J Virol 84(22):11737\u201311746","journal-title":"J Virol"},{"key":"4464_CR31","doi-asserted-by":"crossref","unstructured":"Zou W, Ning K, Xu P, Deng X, Cheng F, Kleiboeker S, et al. 2021 The N-terminal 5\u201368 amino acids domain of the minor capsid protein VP1 of human parvovirus B19 enters human erythroid progenitors and inhibits B19 infection. J Virol; 95(14)","DOI":"10.1128\/JVI.00466-21"},{"issue":"5","key":"4464_CR32","first-page":"708","volume":"16","author":"T Sasaki","year":"1989","unstructured":"Sasaki T, Takahashi Y, Yoshinaga K, Sugamura K, Shiraishi H (1989) An association between human parvovirus B-19 infection and autoantibody production. J Rheumatol 16(5):708\u2013709","journal-title":"J Rheumatol"},{"issue":"14","key":"4464_CR33","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1128\/JVI.78.14.7775-7783.2004","volume":"78","author":"BD Poole","year":"2004","unstructured":"Poole BD, Karetnyi YV, Naides SJ (2004) Parvovirus B19-induced apoptosis of hepatocytes. J Virol 78(14):7775\u20137783","journal-title":"J Virol"},{"issue":"3","key":"4464_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","volume":"15","author":"ED Heegaard","year":"2002","unstructured":"Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15(3):485\u2013505","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"4464_CR35","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1128\/JVI.80.8.4114-4121.2006","volume":"80","author":"BD Poole","year":"2006","unstructured":"Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ (2006) Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol 80(8):4114\u20134121","journal-title":"J Virol"},{"issue":"12","key":"4464_CR36","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1128\/jvi.70.12.8485-8491.1996","volume":"70","author":"S Moffatt","year":"1996","unstructured":"Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O et al (1996) A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 70(12):8485\u20138491","journal-title":"J Virol"},{"issue":"Pt 6","key":"4464_CR37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","volume":"53","author":"A Corcoran","year":"2004","unstructured":"Corcoran A, Doyle S (2004) Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53(Pt 6):459\u2013475","journal-title":"J Med Microbiol"},{"issue":"6","key":"4464_CR38","first-page":"682","volume":"59","author":"Y Tanaka","year":"2018","unstructured":"Tanaka Y, Takahashi Y, Kimura Y, Tomikawa T, Anan T, Sagawa M et al (2018) Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis. Rinsho Ketsueki 59(6):682\u2013687","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"4464_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1182\/bloodadvances.2017013342","volume":"2","author":"JL Espinoza","year":"2018","unstructured":"Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K et al (2018) Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. Blood Adv 2(4):390\u2013400","journal-title":"Blood Adv"},{"issue":"2","key":"4464_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00277-011-1238-8","volume":"91","author":"SH Yang","year":"2012","unstructured":"Yang SH, Lin LW, Fang YJ, Cheng AL, Kuo SH (2012) Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma. Ann Hematol 91(2):291\u2013294","journal-title":"Ann Hematol"},{"issue":"5","key":"4464_CR41","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/infdis\/172.5.1360","volume":"172","author":"M Musiani","year":"1995","unstructured":"Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S (1995) Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 172(5):1360\u20131363","journal-title":"J Infect Dis"},{"issue":"3","key":"4464_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2796.2009.02117.x","volume":"266","author":"G Pongratz","year":"2009","unstructured":"Pongratz G, Lindner J, Modrow S, Schimanski S, Sch\u00f6lmerich J, Fleck M (2009) Persistent parvovirus B19 infection detected by specific CD4+ T-cell responses in a patient with hepatitis and polyarthritis. J Intern Med 266(3):296\u2013301","journal-title":"J Intern Med"},{"issue":"1","key":"4464_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s101560050052","volume":"6","author":"F D\u00edaz","year":"2000","unstructured":"D\u00edaz F, Collazos J (2000) Hepatic dysfunction due to parvovirus B19 infection. J Infect Chemother 6(1):63\u201364","journal-title":"J Infect Chemother"},{"issue":"3","key":"4464_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3892\/ol.2012.548","volume":"3","author":"Y Li","year":"2012","unstructured":"Li Y, Dong Y, Jiang J, Yang Y, Liu K, Li Y (2012) High prevelance of human parvovirus infection in patients with malignant tumors. Oncol Lett 3(3):635\u2013640","journal-title":"Oncol Lett"},{"issue":"11","key":"4464_CR45","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1128\/JCM.40.11.3909-3912.2002","volume":"40","author":"SH Kuo","year":"2002","unstructured":"Kuo SH, Lin LI, Chang CJ, Liu YR, Lin KS, Cheng AL (2002) Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy. J Clin Microbiol 40(11):3909\u20133912","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4464_CR46","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.clinre.2019.12.004","volume":"44","author":"N Gille","year":"2020","unstructured":"Gille N, Roque-Afonso AM, Sebagh M, Rudler M, Thabut D, Duclos-Vall\u00e9e JC et al (2020) Parvovirus B19 infection: a challenging cause of fulminant hepatitis. Clin Res Hepatol Gastroenterol 44(4):e89\u2013e91","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"4464_CR47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","volume":"149","author":"AD Woolf","year":"1989","unstructured":"Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT et al (1989) Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149(5):1153\u20131156","journal-title":"Arch Intern Med"},{"key":"4464_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742990","volume":"12","author":"J Luo","year":"2021","unstructured":"Luo J, Zhang J, Lai W, Wang S, Zhou L, Shi Y et al (2021) Disseminated human parvovirus B19 infection induced multiple organ dysfunction syndrome in an adult patient with alcoholic hepatitis complicated by hemolytic anemia: a case report and literature review. Front Immunol 12:742990","journal-title":"Front Immunol"},{"issue":"10 Suppl 2","key":"4464_CR49","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","volume":"35","author":"JD Siegel","year":"2007","unstructured":"Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35(10 Suppl 2):S65-164","journal-title":"Am J Infect Control"},{"issue":"10","key":"4464_CR50","first-page":"1","volume":"52","author":"L Sehulster","year":"2003","unstructured":"Sehulster L, Chinn RY (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(10):1\u201342","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"4464_CR51","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s007050050699","volume":"144","author":"YV Karetnyi","year":"1999","unstructured":"Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ (1999) Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144(9):1713\u20131724","journal-title":"Arch Virol"},{"issue":"1","key":"4464_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2141.1992.tb06416.x","volume":"80","author":"K Nagai","year":"1992","unstructured":"Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y (1992) Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol 80(1):131\u2013132","journal-title":"Br J Haematol"},{"issue":"4","key":"4464_CR53","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/ajh.2830470424","volume":"47","author":"JC Murray","year":"1994","unstructured":"Murray JC, Morad AB (1994) Childhood autoimmune neutropenia and human parvovirus B19. Am J Hematol 47(4):336","journal-title":"Am J Hematol"},{"issue":"2","key":"4464_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2141.1992.tb08894.x","volume":"80","author":"J Pont","year":"1992","unstructured":"Pont J, Puchhammer-St\u00f6ckl E, Chott A, Popow-Kraupp T, Kienzer H, Postner G et al (1992) Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol 80(2):160\u2013165","journal-title":"Br J Haematol"},{"issue":"8221","key":"4464_CR55","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S0140-6736(81)91579-8","volume":"1","author":"JR Pattison","year":"1981","unstructured":"Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE et al (1981) Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1(8221):664\u2013665","journal-title":"Lancet"},{"issue":"2","key":"4464_CR56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2141.1994.tb04756.x","volume":"86","author":"H Tsuda","year":"1994","unstructured":"Tsuda H, Maeda Y, Nakagawa K, Nakayama M, Nishimura H, Ishihara A et al (1994) Parvovirus B19-associated haemophagocytic syndrome with prominent neutrophilia. Br J Haematol 86(2):413\u2013414","journal-title":"Br J Haematol"},{"issue":"4\u20135","key":"4464_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/10428199209051023","volume":"8","author":"T Petrella","year":"1992","unstructured":"Petrella T, Bailly F, Mugneret F, Caillot D, Chavanet P, Guy H et al (1992) Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemia. Leuk Lymphoma 8(4\u20135):415\u2013419","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"4464_CR58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ajh.2830500317","volume":"50","author":"TJ Smith","year":"1995","unstructured":"Smith TJ, Cullen JW, Peck SD, Brown KE, Young NS (1995) Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphoblastic leukemia, mimicking leukemic relapse. Am J Hematol 50(3):226\u2013227","journal-title":"Am J Hematol"},{"issue":"1","key":"4464_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF01811471","volume":"64","author":"H Baurmann","year":"1992","unstructured":"Baurmann H, Schwarz TF, Oertel J, Serke S, Roggendorf M, Huhn D (1992) Acute parvovirus B19 infection mimicking myelodysplastic syndrome of the bone marrow. Ann Hematol 64(1):43\u201345","journal-title":"Ann Hematol"},{"issue":"1","key":"4464_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2141.1993.tb08645.x","volume":"85","author":"K McClain","year":"1993","unstructured":"McClain K, Estrov Z, Chen H, Mahoney DH Jr. (1993) Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies. Br J Haematol 85(1):57\u201362","journal-title":"Br J Haematol"},{"issue":"2","key":"4464_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1056\/NEJM198507113130203","volume":"313","author":"FA Plummer","year":"1985","unstructured":"Plummer FA, Hammond GW, Forward K, Sekla L, Thompson LM, Jones SE et al (1985) An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med 313(2):74\u201379","journal-title":"N Engl J Med"},{"issue":"2","key":"4464_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0889-857X(05)70014-4","volume":"24","author":"SJ Naides","year":"1998","unstructured":"Naides SJ (1998) Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 24(2):375\u2013401","journal-title":"Rheum Dis Clin North Am"},{"issue":"9","key":"4464_CR63","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/art.1780330901","volume":"33","author":"SJ Naides","year":"1990","unstructured":"Naides SJ, Scharosch LL, Foto F, Howard EJ (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum 33(9):1297\u20131309","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4464_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1568-9972(03)00014-4","volume":"2","author":"HW Lehmann","year":"2003","unstructured":"Lehmann HW, von Landenberg P, Modrow S (2003) Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2(4):218\u2013223","journal-title":"Autoimmun Rev"},{"key":"4464_CR65","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/472027","author":"C Bihari","year":"2013","unstructured":"Bihari C, Rastogi A, Saxena P, Rangegowda D, Chowdhury A, Gupta N et al (2013) Parvovirus b19 associated hepatitis. Hepat Res Treat. https:\/\/doi.org\/10.1155\/2013\/472027","journal-title":"Hepat Res Treat"},{"key":"4464_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-6","volume":"14","author":"M Koliou","year":"2014","unstructured":"Koliou M, Karaoli E, Soteriades ES, Pavlides S, Bashiardes S, Christodoulou C (2014) Acute hepatitis and myositis associated with erythema infectiosum by parvovirus B19 in an adolescent. BMC Pediatr 14:6","journal-title":"BMC Pediatr"},{"issue":"5","key":"4464_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/(SICI)1099-0496(199811)26:5<365::AID-PPUL11>3.0.CO;2-4","volume":"26","author":"A Bousvaros","year":"1998","unstructured":"Bousvaros A, Sundel R, Thorne GM, McIntosh K, Cohen M, Erdman DD et al (1998) Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol 26(5):365\u2013369","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"4464_CR68","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/517644","volume":"26","author":"G Longo","year":"1998","unstructured":"Longo G, Luppi M, Bertesi M, Ferrara L, Torelli G, Emilia G (1998) Still\u2019s disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis 26(4):994\u2013995","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4464_CR69","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/01.inf.0000183768.84890.ae","volume":"24","author":"C Ferraz","year":"2005","unstructured":"Ferraz C, Cunha F, Mota TC, Carvalho JM, Sim\u00f5es JS, Aparicio JM (2005) Acute respiratory distress syndrome in a child with human parvovirus B19 infection. Pediatr Infect Dis J 24(11):1009\u20131010","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"4464_CR70","first-page":"180","volume":"15","author":"A Shauer","year":"2013","unstructured":"Shauer A, Gotsman I, Keren A, Zwas DR, Hellman Y, Durst R et al (2013) Acute viral myocarditis: current concepts in diagnosis and treatment. Isr Med Assoc J 15(3):180\u2013185","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"4464_CR71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-2007-994673","volume":"9","author":"CP Weiner","year":"1992","unstructured":"Weiner CP, Naides SJ (1992) Fetal survival after human parvovirus B19 infection: spectrum of intrauterine response in a twin gestation. Am J Perinatol 9(1):66\u201368","journal-title":"Am J Perinatol"},{"issue":"9107","key":"4464_CR72","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(05)60609-5","volume":"351","author":"JG Hillingso","year":"1998","unstructured":"Hillingso JG, Jensen IP (1998) Parvovirus B19 and acute hepatitis in adults. The Lancet 351(9107):955\u2013956","journal-title":"The Lancet"},{"issue":"10","key":"4464_CR73","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1086\/374781","volume":"187","author":"S Wong","year":"2003","unstructured":"Wong S, Young NS, Brown KE (2003) Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187(10):1581\u20131586","journal-title":"J Infect Dis"},{"issue":"Pt 6","key":"4464_CR74","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1099\/0022-1317-73-6-1559","volume":"73","author":"NP Miki","year":"1992","unstructured":"Miki NP, Chantler JK (1992) Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro. J Gen Virol 73(Pt 6):1559\u20131562","journal-title":"J Gen Virol"},{"issue":"12","key":"4464_CR75","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/jmv.21638","volume":"81","author":"C Wang","year":"2009","unstructured":"Wang C, Heim A, Schlaphoff V, Suneetha PV, Stegmann KA, Jiang H et al (2009) Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis. J Med Virol 81(12):2079\u20132088","journal-title":"J Med Virol"},{"issue":"3","key":"4464_CR76","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jhep.2006.03.013","volume":"45","author":"NL Toan","year":"2006","unstructured":"Toan NL, Song leH, Kremsner PG, Duy DN, Binh VQ, Duechting A et al (2006) Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol 45(3):361\u2013369","journal-title":"J Hepatol"},{"issue":"2","key":"4464_CR77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jmv.2047","volume":"65","author":"AM Eis-H\u00fcbinger","year":"2001","unstructured":"Eis-H\u00fcbinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, P\u00fctz U (2001) Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65(2):395\u2013401","journal-title":"J Med Virol"},{"issue":"10","key":"4464_CR78","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1007\/s10620-005-9061-5","volume":"51","author":"WM Lee","year":"2006","unstructured":"Lee WM, Brown KE, Young NS, Dawson GJ, Schlauder GG, Gutierrez RA et al (2006) Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci 51(10):1712\u20131715","journal-title":"Dig Dis Sci"},{"issue":"7","key":"4464_CR79","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/INF.0b013e318198d05c","volume":"28","author":"M Dwivedi","year":"2009","unstructured":"Dwivedi M, Manocha H, Tiwari S, Tripathi G, Dhole TN (2009) Coinfection of parvovirus B19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr Infect Dis J 28(7):649\u2013650","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"4464_CR80","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1440-1746.2005.03815.x","volume":"20","author":"TC Hsu","year":"2005","unstructured":"Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ (2005) Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20(5):733\u2013738","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"4464_CR81","first-page":"148","volume":"17","author":"F Oz\u00e7ay","year":"2006","unstructured":"Oz\u00e7ay F, Bikmaz YE, Canan O, Ozbek N (2006) Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure. Turk J Gastroenterol 17(2):148\u2013150","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"4464_CR82","volume":"14","author":"U Khan","year":"2022","unstructured":"Khan U, Uzair Ahmad R, Ullah Z, Fida T, Shehryar M (2022) Parvovirus b19-induced acute hepatitis with hepatosplenomegaly and polyarthropathy. Cureus 14(1):e21494","journal-title":"Cureus"},{"issue":"3","key":"4464_CR83","first-page":"444","volume":"70","author":"B Sobala-Szczygie\u0142","year":"2016","unstructured":"Sobala-Szczygie\u0142 B, Boro\u0144-Kaczmarska A, K\u0119pa L, Oczko-Grzesik B, Piotrowski D, Stolarz W (2016) Acute liver failure during treatment of interferon alpha 2a chronic hepatitis B and coinfection of parvovirus B19. Przegl Epidemiol 70(3):444\u2013448","journal-title":"Przegl Epidemiol"},{"key":"4464_CR84","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijid.2014.08.003","volume":"28","author":"M Karrasch","year":"2014","unstructured":"Karrasch M, Felber J, Keller PM, Kletta C, Egerer R, Bohnert J et al (2014) Primary Epstein-Barr virus infection and probable parvovirus B19 reactivation resulting in fulminant hepatitis and fulfilling five of eight criteria for hemophagocytic lymphohistiocytosis. Int J Infect Dis 28:143\u2013146","journal-title":"Int J Infect Dis"},{"issue":"1","key":"4464_CR85","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.clinre.2013.06.009","volume":"38","author":"C Bihari","year":"2014","unstructured":"Bihari C, Rastogi A, Rangegowda D, Chowdhury A, Saxena P, Garg H et al (2014) Parvovirus B19 associated acute hepatitis and hepatosplenomegaly. Clin Res Hepatol Gastroenterol 38(1):e9-10","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"4464_CR86","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.gastrohep.2012.04.012","volume":"35","author":"JM Gonz\u00e1lez","year":"2012","unstructured":"Gonz\u00e1lez JM, Lalastra CS, Gismero FM, Vicente VM (2012) Una causa excepcional de hepatitis aguda en el adulto: parvovirus B19. Gastroenterol Hepatol 35(10):697\u2013699","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"4464_CR87","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10620-012-2110-y","volume":"57","author":"RJ Huang","year":"2012","unstructured":"Huang RJ, Varr BC, Triadafilopoulos G (2012) Acute fulminant hepatic failure associated with parvovirus B19 infection in an immunocompetent adult. Dig Dis Sci 57(11):2811\u20132813","journal-title":"Dig Dis Sci"},{"issue":"1","key":"4464_CR88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/hep.24720","volume":"55","author":"L Sun","year":"2012","unstructured":"Sun L, Zhang JC (2012) Acute fulminant hepatitis with bone marrow failure in an adult due to parvovirus B19 infection. Hepatology 55(1):329\u2013330","journal-title":"Hepatology"},{"issue":"9","key":"4464_CR89","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1128\/JCM.00575-11","volume":"49","author":"A Hatakka","year":"2011","unstructured":"Hatakka A, Klein J, He R, Piper J, Tam E, Walkty A (2011) Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol 49(9):3422\u20133424","journal-title":"J Clin Microbiol"},{"issue":"6-7","key":"4464_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/00365548.2011.554856","volume":"43","author":"L Sun","year":"2011","unstructured":"Sun L, Zhang JC, Jia ZS (2011) Association of parvovirus B19 infection with acute icteric hepatitis in adults. Scand J Infect Dis 43(6\u20137):547\u2013549","journal-title":"Scand J Infect Dis"},{"key":"4464_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-246","volume":"10","author":"TH Mogensen","year":"2010","unstructured":"Mogensen TH, Jensen JM, Hamilton-Dutoit S, Larsen CS (2010) Chronic hepatitis caused by persistent parvovirus B19 infection. BMC Infect Dis 10:246","journal-title":"BMC Infect Dis"},{"issue":"32","key":"4464_CR92","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.3748\/wjg.15.4067","volume":"15","author":"DS Krygier","year":"2009","unstructured":"Krygier DS, Steinbrecher UP, Petric M, Erb SR, Chung SW, Scudamore CH et al (2009) Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol 15(32):4067\u20134069","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4464_CR93","first-page":"115","volume":"2","author":"JQ Lian","year":"2009","unstructured":"Lian JQ, Zhang Y, Liu L, Bai XG, Liang ZJ, Zhao YY et al (2009) Acute liver failure and myelosuppression due to parvovirus B19 infection: a case report. Gastroenterology Res 2(2):115\u2013117","journal-title":"Gastroenterology Res"},{"issue":"1","key":"4464_CR94","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0168-8278(02)00090-9","volume":"37","author":"A Chehal","year":"2002","unstructured":"Chehal A, Sharara AI, Abi Haidar H, Haidar J, Bazarbachi A (2002) Acute viral hepatitis A and parvovirus B19 infections complicated by pure red cell aplasia and autoimmune hemolytic anemia. J Hepatol 37(1):163\u2013165","journal-title":"J Hepatol"},{"issue":"4","key":"4464_CR95","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1046\/j.1365-2141.2002.03741.x","volume":"118","author":"F Hayakawa","year":"2002","unstructured":"Hayakawa F, Imada K, Towatari M, Saito H (2002) Life\u2010threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br J Haematol 118(4):1187\u20131189","journal-title":"Br J Haematol"},{"issue":"1","key":"4464_CR96","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s100960000418","volume":"20","author":"C Alliot","year":"2001","unstructured":"Alliot C, Barrios M, Taib J, Brunel M (2001) Parovirus B19 infection in an HIV-infected patient with febrile pancytopenia and acute hepatitis. Eur J Clin Microbiol Infect Dis 20(1):43\u201345","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4464_CR97","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1365-2133.1999.02943.x","volume":"141","author":"F Drago","year":"1999","unstructured":"Drago F, Semino M, Rampini P, Rebora A (1999) Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 141(1):160\u2013161","journal-title":"Br J Dermatol"},{"issue":"3","key":"4464_CR98","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1572-0241.1998.468_1.x","volume":"93","author":"DS Pardi","year":"1998","unstructured":"Pardi DS, Romero Y, Mertz LE, Douglas DD (1998) Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 93(3):468\u2013470","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"4464_CR99","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/BF01690517","volume":"15","author":"S Nikkari","year":"1996","unstructured":"Nikkari S, Lappalainen H, Saario R, Lammintausta K, Kotilainen P (1996) Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis. Eur J Clin Microbiol Infect Dis 15(12):954\u2013957","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4464_CR100","doi-asserted-by":"crossref","unstructured":"Weinberg JM, Wolfe JT, Frattali AL, Werth VP, Naides SJ, Spiers EM. 1996 Parvovirus B19 infection associated with acute hepatitis, arthralgias, and rash. JCR: J Clin Rheumatol. 2(2)","DOI":"10.1097\/00124743-199604000-00005"},{"issue":"1","key":"4464_CR101","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2019.06.043","volume":"82","author":"YH Jang","year":"2020","unstructured":"Jang YH, Kim SM, Eun DH, Park KD, Park G-H, Kim B-S et al (2020) Validity and reliability of itch assessment scales for chronic pruritus in adults: a prospective multicenter study. J Am Acad Dermatol 82(1):80\u201386","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4464_CR102","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"1","key":"4464_CR103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2020.02.007","volume":"73","author":"DBE van Wessel","year":"2020","unstructured":"van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T et al (2020) Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol 73(1):84\u201393","journal-title":"J Hepatol"},{"issue":"2","key":"4464_CR104","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jhep.2024.04.006","volume":"81","author":"HJ Verkade","year":"2024","unstructured":"Verkade HJ, Felzen A, Keitel V, Thompson R, Gonzales E, Strnad P et al (2024) EASL Clinical Practice Guidelines on genetic cholestatic liver diseases. J Hepatol 81(2):303\u2013325","journal-title":"J Hepatol"},{"issue":"12","key":"4464_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0315243","volume":"19","author":"C Angendohr","year":"2024","unstructured":"Angendohr C, Missing L, Ehlting C, Wolf SD, Lang KS, Vucur M et al (2024) Interleukin 1 \u03b2 suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism. PLoS ONE 19(12):e0315243","journal-title":"PLoS ONE"},{"issue":"8","key":"4464_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70216","volume":"45","author":"A Di Giorgio","year":"2025","unstructured":"Di Giorgio A, Blokzijl H, Gonzal\u00e8s E, Salcedo M, van der Woerd WL, Clemson C et al (2025) Odevixibat for episodic intrahepatic cholestasis due to biallelic mutations in ATP8B1: a case series. Liver Int 45(8):e70216","journal-title":"Liver Int"},{"issue":"1","key":"4464_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101625","volume":"8","author":"RJ Thompson","year":"2026","unstructured":"Thompson RJ, Vilarinho S, Miquel R, Keitel V (2026) Challenges in the diagnosis and treatment of genetic cholestasis in adults. JHEP Rep 8(1):101625","journal-title":"JHEP Rep"},{"key":"4464_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247508","author":"M Marx","year":"2024","unstructured":"Marx M, Hartleif S, Hilberath J, Berg CP, Tsiflikas I, Singer S et al (2024) Practical considerations for odevixibat treatment in patients with progressive familial intrahepatic cholestasis: a single-center case series. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13247508","journal-title":"J Clin Med"},{"key":"4464_CR109","unstructured":"Annex I. 1999 Summary of product characteristics. Committee for Proprietary Medicinal Products. The European Public Assessment Report (EPAR) Stocrin. The European Agency for the Evaluation of Medicinal Products, London"},{"key":"4464_CR110","unstructured":"Nordisk N. 2023 Saxenda\u00ae summary of product characteristics 2024"},{"issue":"9","key":"4464_CR111","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","volume":"7","author":"RJ Thompson","year":"2022","unstructured":"Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P et al (2022) Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol 7(9):830\u2013842","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04464-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:02:08Z","timestamp":1784876528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":111,"alternative-id":["4464"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04464-1","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Fabio Piscaglia has received honoraria for serving as a consultant, advisory board member, and speaker from AstraZeneca, Bracco, Bristol Myers Squibb (BMS), Eisai, MSD, Esaote, Roche, Novo Nordisk, Siemens Healthineers, Samsung, Signant Health, Ipsen, Gilead Sciences, and GE HealthCare. Giovanni Vitale has received honoraria for participation in seminars, webinars, and advisory boards from Ipsen, Mirum Pharmaceuticals, Novartis, and Amgen during the past two years.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}